![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Chromo Laboratories India Private Limited Pashamylaram In, based in India, is a pharmaceutical company.
One of their significant offerings is Repaglinide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-087 - Rev 00
This Chemical Type CEP, issued on September 27, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2135 associated with this CEP further emphasizes